Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Geno Germano to the new role ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE